✦ LIBER ✦

Relapsing multiple sclerosis patients treated with disease modifying therapy exhibit highly variable disease progression: A predictive model

✍ Scribed by Scott, Thomas F.; Hackett, Christopher T.; Quigley, Matthew R.; Schramke, Carol J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND7 Disability Progression in Patients

✍ R. Hettle; J. Murphy; B. Eckert 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

The UK patient experience of relapse in

✍ Duddy, Martin; Lee, Martin; Pearson, Owen; Nikfekr, Esmaeil; Chaudhuri, Abhijit; 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 484 KB

Alemtuzumab for patients with relapsing

✍ Alasdair J Coles; Cary L Twyman; Douglas L Arnold; Jeffrey A Cohen; Christian Co 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 326 KB

PND19 A LONG-TERM COST-EFFECTIVENESS MAR

✍ C Plesnila-Frank; N Putzki; D Eheberg; V Limmroth; Z Katsarava; SN Patel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

The Global Adherence Project (GAP): a mu

✍ V. Devonshire; Y. Lapierre; R. Macdonell; C. Ramo-Tello; F. Patti; P. Fontoura; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB